LCBiot-SFIEDLLFNKVTLADAGF-OH

Ref. 3D-PP48793

Produktinformation

• Name: LCBiot-SFIEDLLFNKVTLADAGF-OH

Beschreibung

Peptide LCBiot-SFIEDLLFNKVTLADAGF-OH is a Research Peptide with significant interest within the field academic and medical research. This peptide is available for purchase at Cymit Quimica in multiple sizes and with a specification of your choice. Recent citations using LCBiot-SFIEDLLFNKVTLADAGF-OH include the following: Mechanisms of coronavirus cell entry mediated by the viral spike protein S Belouzard, JK Millet , BN Licitra, GR Whittaker - Viruses, 2012 - mdpi.comhttps://www.mdpi.com/1999-4915/4/6/1011?utm_source=dlvr.it&utm_medium=twitter Identification of a severe acute respiratory syndrome coronavirus-like virus in a leaf-nosed bat in Nigeria PL Quan, C Firth , C Street , JA Henriquez, A Petrosov - MBio, 2010 - Am Soc Microbiolhttps://journals.asm.org/doi/abs/10.1128/mBio.00208-10 A novel bispecific antibody dual-targeting approach for enhanced neutralization against fast-evolving SARS-CoV-2 variants JW Kim, HJ Kim, K Heo, Y Lee, HJ Jang - Frontiers in , 2023 - frontiersin.orghttps://www.frontiersin.org/articles/10.3389/fimmu.2023.1271508/full Physiological and molecular triggers for SARS-CoV membrane fusion and entry into host cells JK Millet , GR Whittaker - Virology, 2018 - Elsevierhttps://www.sciencedirect.com/science/article/pii/S0042682217304208 of a highly conserved domain within the severe acute respiratory syndrome coronavirus spike protein S2 domain with characteristics of a viral fusion peptide IG Madu , SL Roth, S Belouzard, GR Whittaker - Journal of virology, 2009 - Am Soc Microbiolhttps://journals.asm.org/doi/abs/10.1128/jvi.00079-09 Characterization of a highly conserved domain within the SARS coronavirus spike protein S2 domain with characteristics of a viral fusion peptide IG Madu , SL Roth, S Belouzard, GR Whittaker - J Virol, 2009 - Citeseerhttps://citeseerx.ist.psu.edu/document?repid=rep1&type=pdf&doi=b0802b79b919ce83b0d0958859035d1d70f96cd6 SARS-CoV-2 and COVID-19 Pathogenesis: A Review G Burmer, M Burmer, V Pabuwal - 2020 - stratech.co.ukhttps://www.stratech.co.uk/wp-content/uploads/2020/07/LifeSpan-BioSciences-SARS-CoV-2-And-COVID-19-Pathogenesis-A-Review.pdf A fusion peptide in the spike protein of MERS coronavirus EAJ Alsaadi , BW Neuman , IM Jones - Viruses, 2019 - mdpi.comhttps://www.mdpi.com/1999-4915/11/9/825 Killed whole-genome reduced-bacteria surface-expressed coronavirus fusion peptide vaccines protect against disease in a porcine model DLNF Maeda, D Tian , H Yu, N Dar - Proceedings of the , 2021 - National Acad Scienceshttps://www.pnas.org/doi/abs/10.1073/pnas.2025622118 Epitope-directed anti-SARS-CoV-2 scFv engineered against the key spike protein region could block membrane fusion D Jaiswal, U Kumar, V Gaur , DM Salunke - Protein Science, 2023 - Wiley Online Libraryhttps://onlinelibrary.wiley.com/doi/abs/10.1002/pro.4575 The SARS-CoV fusion peptide forms an extended bipartite fusion platform that perturbs membrane order in a calcium-dependent manner AL Lai, JK Millet , S Daniel , JH Freed - Journal of molecular , 2017 - Elsevierhttps://www.sciencedirect.com/science/article/pii/S0022283617304990

• Marke: Biosynth